Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Apr 16, 2023
Date Accepted: Jun 24, 2024

The final, peer-reviewed published version of this preprint can be found here:

Correlation Between Electronic Patient-Reported Outcomes and Biological Markers of Key Parameters in Acute Radiation Cystitis Among Patients With Prostate Cancer (RABBIO): Prospective Observational Study

Helissey C, CAVALLERO S, GUITARD N, THERY H, PARNOT C, SCHERNBERG A, AISSA I, RAFFIN F, LE COZ C, MONDOT S, Christopoulos C, MALEK K, MALAURIE E, Blanchard P, CHARGARI C, FRANCOIS S

Correlation Between Electronic Patient-Reported Outcomes and Biological Markers of Key Parameters in Acute Radiation Cystitis Among Patients With Prostate Cancer (RABBIO): Prospective Observational Study

JMIR Cancer 2024;10:e48225

DOI: 10.2196/48225

PMID: 39665773

PMCID: 11656992

Correlation between electronic Patient Reported Outcomes and biological markers, key parameter in acute radiation cystitis among prostate cancer patients: RABBIO, a prospective observational study.

  • Carole Helissey; 
  • Sophie CAVALLERO; 
  • Nathalie GUITARD; 
  • Hélène THERY; 
  • Charles PARNOT; 
  • Antoine SCHERNBERG; 
  • Imen AISSA; 
  • Florent RAFFIN; 
  • Christine LE COZ; 
  • Stanislas MONDOT; 
  • Christos Christopoulos; 
  • Karim MALEK; 
  • Emmanuelle MALAURIE; 
  • Pierre Blanchard; 
  • Cyrus CHARGARI; 
  • Sabine FRANCOIS

ABSTRACT

Background:

Despite advances in radiation techniques, radiation cystitis (RC) remains a significant cause of morbidity from pelvic radiotherapy, which may affect patients' quality of life (QoL). The pathophysiology of RC is not well understood, which limits the development of effective treatments.

Objective:

The RABBIO study aims to investigate the correlation between blood and urinary biomarkers and the intensity of acute RC symptoms and QoL in patients undergoing localized prostate cancer radiotherapy.

Methods:

The study included patients with low or intermediate-risk localized prostate cancer who were eligible for localized radiotherapy. Blood and urinary biomarkers were analyzed before radiotherapy was initiated and at weeks 4 and 12 of radiation therapy. Patients completed questionnaires related to radiation cystitis symptoms and QoL using a digital remote monitoring platform. The information was processed by means of an algorithm which classified patients according to the severity of symptoms and adverse events reported. Levels of blood and urinary biomarkers were correlated with the severity of acute RC symptoms and patient-reported QoL.

Results:

401 adverse events’ questionnaires were collected over the duration of the study. The most frequently reported adverse events at week 4 were pollakiuria, constipation, and diarrhea. In comparison with baseline, the mean Functional Assessment of Cancer Therapy-Prostate (FACT-P) score decreased at week 4. A significant polarization of M2-phenotype macrophages and increase in serum and urine levels of M-CSF, HGF, and MIP-1α over baseline were observed at week 12. Baseline serum and urine M-CSF concentrations showed a significant negative correlation with FACT–P scores at weeks 4 and 12.

Conclusions:

The RABBIO study is the first to explore the overexpression of inflammatory proteins in fluid biopsies from patients with symptoms of acute RC. These preliminary findings suggest that serum and urine HGF, M-CSF, MIP-1α, as well as macrophage polarization are potential biomarkers of cystitis after prostate radiotherapy. The elevated M-CSF levels in serum and urine at baseline were associated with the deterioration of QoL during radiotherapy. The results of this study may help to develop mitigation strategies to limit radiation damage to the bladder. Clinical Trial: NCT05246774


 Citation

Please cite as:

Helissey C, CAVALLERO S, GUITARD N, THERY H, PARNOT C, SCHERNBERG A, AISSA I, RAFFIN F, LE COZ C, MONDOT S, Christopoulos C, MALEK K, MALAURIE E, Blanchard P, CHARGARI C, FRANCOIS S

Correlation Between Electronic Patient-Reported Outcomes and Biological Markers of Key Parameters in Acute Radiation Cystitis Among Patients With Prostate Cancer (RABBIO): Prospective Observational Study

JMIR Cancer 2024;10:e48225

DOI: 10.2196/48225

PMID: 39665773

PMCID: 11656992

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.